Compound Detail
CHEMBL314854
FINGOLIMOD 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL314854 |
| Name | FINGOLIMOD |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | KKGQTZUTZRNORY-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
| Active Moiety | CHEMBL366208 |
27
Targets
49
Activities
4
Assay Types
16
PK Parameters
20
Publications
2
Known Names
17
Indications
Molecular Properties
307.5
MW (Da)
3.20
ALogP
3
HBA
3
HBD
66.5
PSA (Ų)
0.52
QED
0
Ro5 Violations
12
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2010 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Multiple Sclerosis Multiple Sclerosis, Chronic Progressive Multiple Sclerosis, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Asthma Optic Neuritis Schizophrenia Severe Acute Respiratory Syndrome Stroke Uveitis Breast Neoplasms Cerebral Hemorrhage Renal Insufficiency Rett Syndrome Astrocytoma Glioblastoma
ATC Classification
L04AE01
fingolimod
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: IMMUNOSUPPRESSANTS
Activity Summary
IC50 36 meas. best 8.21
EC50 10 meas. best 9.52
Kd 2 meas. best 5.3
Ki 1 meas. best 5.67
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sphingosine 1-phosphate receptor 5 CHEMBL2274 | EC50 | 9.52 | 7.51 | 0.3 | 2 |
| Sphingosine 1-phosphate receptor 1 CHEMBL4333 | EC50 | 9.52 | 7.932 | 0.3 | 5 |
| Sphingosine 1-phosphate receptor 4 CHEMBL3230 | EC50 | 9.52 | 9.52 | 0.3 | 1 |
| Sphingosine 1-phosphate receptor 3 CHEMBL3892 | EC50 | 8.52 | 7.06 | 3.0 | 2 |
| Mus musculus CHEMBL375 | IC50 | 8.21 | 7.69 | 6.1 | 2 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 8.21 | 5.884 | 6.1 | 5 |
| Sphingosine 1-phosphate receptor 1 CHEMBL4333 | IC50 | 6.22 | 6.15 | 603.8 | 2 |
| Transient receptor potential cation channel subfamily M member 7 CHEMBL3714706 | IC50 | 6.14 | 6.14 | 720.0 | 1 |
| Sphingosine 1-phosphate receptor 5 CHEMBL2274 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| FL5.12 CHEMBL4296414 | IC50 | 5.68 | 5.65 | 2100.0 | 2 |
| Ceramide synthase 2 CHEMBL5291553 | Ki | 5.67 | 5.67 | 2150.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.54 | 5.42 | 2900.0 | 2 |
| G-protein coupled receptor 183 CHEMBL3259470 | IC50 | 5.38 | 5.38 | 4219.1 | 1 |
| SH-SY5Y CHEMBL614910 | IC50 | 5.33 | 5.33 | 4710.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Troponin C, slow skeletal and cardiac muscles CHEMBL2066 | Kd | 5.3 | 5.255 | 5000.0 | 2 |
| SW-620 CHEMBL612262 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| SK-BR-3 CHEMBL613834 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.26 | 5.1733 | 5500.0 | 3 |
| SK-N-AS CHEMBL1075578 | IC50 | 5.21 | 5.21 | 6110.0 | 1 |
| BV-173 CHEMBL2366145 | IC50 | 5.2 | 5.2 | 6300.0 | 1 |
| Ceramide synthase 2 CHEMBL5291553 | IC50 | 5.19 | 5.19 | 6400.0 | 1 |
| DU-145 CHEMBL613508 | IC50 | 5.19 | 5.19 | 6500.0 | 1 |
| CCRF-CEM CHEMBL382 | IC50 | 5.17 | 5.17 | 6800.0 | 1 |
| BT-474 CHEMBL614529 | IC50 | 5.07 | 5.07 | 8500.0 | 1 |
| NALM-6 CHEMBL614187 | IC50 | 5.02 | 5.02 | 9600.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 5.01 | 5.01 | 9800.0 | 1 |
| Sphingosine-1-phosphate lyase 1 CHEMBL3286061 | IC50 | 4.77 | 4.525 | 17000.0 | 2 |
| Troponin C, slow skeletal and cardiac muscles CHEMBL2066 | IC50 | 4.54 | 4.54 | 29100.0 | 1 |
| Sphingosine-1-phosphate lyase 1 CHEMBL5009 | IC50 | 4.28 | 4.28 | 52400.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 200.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 319.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | - | - | Homo sapiens |
| Cmax | 110.58 | nM | Rattus norvegicus |
| Cmax | 42.93 | nM | Rattus norvegicus |
| T1/2 | 216.0 | hr | Homo sapiens |
| T1/2 | 89.0 | hr | Homo sapiens |
| T1/2 | 32.0 | hr | Rattus norvegicus |
| T1/2 | 4.1 | hr | Rattus norvegicus |
| T1/2 | 18.9 | hr | Rattus norvegicus |
| T1/2 | 120.0 | hr | Homo sapiens |
| T1/2 | 216.0 | hr | Homo sapiens |
| t1/2 | - | - | Homo sapiens |
| T1/2 | 168.0 | hr | Homo sapiens |
| T1/2 | 144.0 | hr | Homo sapiens |
| Tmax | 8.4 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36598820 | 10.1021/acs.jnatprod.2c00798 | Mus musculus | 66 |
| 27913115 | 10.1016/j.bmc.2016.11.015 | SK-N-SH | 53 |
| 27913115 | 10.1016/j.bmc.2016.11.015 | SH-SY5Y | 53 |
| 27913115 | 10.1016/j.bmc.2016.11.015 | U-118-MG | 44 |
| 26985316 | 10.1021/acsmedchemlett.5b00448 | Mus musculus | 16 |
| - | 10.1016/0960-894X(95)00127-F | Rattus norvegicus | 11 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 8 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 8 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 8 |
| - | 10.6019/CHEMBL5058564 | U2OS | 8 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 8 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 8 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 8 |
Data from ChEMBL 36 via Core Engine